Protective effects of Peroxiredoxin 6 overexpression on amyloid beta-induced apoptosis in PC12 cells
- Authors
- Kim, I. K.; Lee, K. J.; Rhee, Sang Myung; Seo, Sang Beom; Pak, Jhang Ho
- Issue Date
- Oct-2013
- Publisher
- INFORMA HEALTHCARE
- Keywords
- Alzheimer's disease; amyloid beta; oxidative stress; apoptosis; peroxiredoxin 6
- Citation
- FREE RADICAL RESEARCH, v.47, no.10, pp 836 - 846
- Pages
- 11
- Journal Title
- FREE RADICAL RESEARCH
- Volume
- 47
- Number
- 10
- Start Page
- 836
- End Page
- 846
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/14245
- DOI
- 10.3109/10715762.2013.833330
- ISSN
- 1071-5762
1029-2470
- Abstract
- Oxidative stress triggered by amyloid beta (A beta) accumulation contributes substantially to the pathogenesis of Alzheimer's disease (AD). In the present study, we examined the involvement of the antioxidant activity of peroxiredoxin 6 (Prdx 6) in protecting against A beta(25-35)-induced neurotoxicity in rat PC12 cells. Treatment of PC12 cells with A beta(25-35) resulted in a dose- and time-dependent cytotoxicity that was associated with increased accumulation of intracellular reactive oxygen species (ROS) and mitochondria-mediated apoptotic cell death, including activation of Caspase 3 and 9, inactivation of poly ADP-ribosyl polymerse (PARP), and dysregulation of Bcl-2 and Bax. This apoptotic signaling machinery was markedly attenuated in PC12 cells that overexpress wild-type Prdx 6, but not in cells that overexpress the C47S catalytic mutant of Prdx 6. This indicates that the peroxidase activity of Prdx 6 protects PC12 cells from A beta(25-35)-induced neurotoxicity. The neuroprotective role of the antioxidant Prdx 6 suggests its therapeutic and/or prophylactic potential to slow the progression of AD and limit the extent of neuronal cell death caused by AD.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Natural Sciences > Department of Life Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.